Cartesian Therapeutics, Inc. (RNAC)
NASDAQ·Healthcare·Biotechnology
$8.20
+4.19%
Mkt Cap $299.10M
Analyst Ratings
Buy
10
Hold
0
Sell
0
Price Target (5 analysts)
$20.50
Range $16.00 – $25.00
Implied Upside
+150.0%
Consensus $20.50 vs current $8.20
NASDAQ·Healthcare·Biotechnology
$8.20
+4.19%
Mkt Cap $299.10M
Buy
10
Hold
0
Sell
0
Price Target (5 analysts)
$20.50
Range $16.00 – $25.00
+150.0%
Consensus $20.50 vs current $8.20